Skip to content
OpenSampling

The Library

Papers on microsampling and monitoring, each with a finding paraphrased to our standard and labelled in one vocabulary. With a free account, every entry links to a legitimate copy; nothing is copied from an abstract.

Papers 1–5 of 7 labelled “HemaXis DB10”, newest first.

  1. 2026

    Clinical Validation of Venetoclax Volumetric Microsampling in Leukemia, with Whole-Blood-to-Plasma Conversion and Self-Microsampling Feasibility

    In AML and CLL, 91% of VAMS venetoclax results fell within 20% of plasma after individualised haematocrit correction; in home sampling,

    Levens et al., Clinical Pharmacokinetics (paywalled)

  2. 2025

  3. 2023

    Clinical sensitivity and specificity of a high-throughput microfluidic nano-immunoassay combined with capillary blood microsampling for the identification of anti-SARS-CoV-2 Spike IgG serostatus

    In participants 11 months after SARS-CoV-2 infection, the nano-immunoassay achieved 98.33% sensitivity and 97.62% specificity on venous serum.

    Michielin et al., PloS one

  4. 2023

    Results From a Proficiency Testing Pilot for Immunosuppressant Microsampling Assays

    Microsampling assays for immunosuppressant monitoring showed three- to fourfold higher imprecision across 14 laboratories than conventional whole-blood analysis, with coefficients of variation of 11.7 to 18.6 percent versus 3.9 to 4.9 percent.

    Veenhof et al., Therapeutic drug monitoring

  5. 2022

    Volumetric microsampling for simultaneous remote immunosuppressant and kidney function monitoring in outpatient kidney transplant recipients

    Validated a dried blood spot assay for tacrolimus and mycophenolic acid therapeutic drug monitoring and creatinine-based kidney function in kidney transplant recipients.

    Zwart et al., British journal of clinical pharmacology

Browse the whole Library with a free account

A free account opens every page of every view, search, and every finding in full with its source.

Read from the corpus on .